| Literature DB >> 29720448 |
Jehane Fadlallah1, Hela El Kafsi1, Delphine Sterlin1,2, Catherine Juste3, Christophe Parizot2, Karim Dorgham1, Gaëlle Autaa1, Doriane Gouas1, Mathieu Almeida4, Patricia Lepage3, Nicolas Pons5, Emmanuelle Le Chatelier5, Florence Levenez5, Sean Kennedy5, Nathalie Galleron5, Jean-Paul Pais de Barros6,7, Marion Malphettes8, Lionel Galicier8, David Boutboul8,9, Alexis Mathian10, Makoto Miyara1,2, Eric Oksenhendler8,11, Zahir Amoura1,10, Joel Doré3,5, Claire Fieschi8,9, S Dusko Ehrlich5,12, Martin Larsen13,2, Guy Gorochov13,2.
Abstract
Paradoxically, loss of immunoglobulin A (IgA), one of the most abundant antibodies, does not irrevocably lead to severe infections in humans but rather is associated with relatively mild respiratory infections, atopy, and autoimmunity. IgA might therefore also play covert roles, not uniquely associated with control of pathogens. We show that human IgA deficiency is not associated with massive quantitative perturbations of gut microbial ecology. Metagenomic analysis highlights an expected pathobiont expansion but a less expected depletion in some typically beneficial symbionts. Gut colonization by species usually present in the oropharynx is also reminiscent of spatial microbiota disorganization. IgM only partially rescues IgA deficiency because not all typical IgA targets are efficiently bound by IgM in the intestinal lumen. Together, IgA appears to play a nonredundant role at the forefront of the immune/microbial interface, away from the intestinal barrier, ranging from pathobiont control and regulation of systemic inflammation to preservation of commensal diversity and community networks.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29720448 DOI: 10.1126/scitranslmed.aan1217
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956